In the Market: Ceres in Thousand Oaks.

In the months leading up to Kythera Biopharmaceuticals Inc. transitioning from a private company to a public one last year, the Calabasas drug maker put in place accounting procedures to give transparency to its financial reporting....

Subscribe to get the full story.

Are you a subscriber? Sign In